pyrrolidone hydrotribromide
Names
[ CAS No. ]:
22580-55-8
[ Name ]:
pyrrolidone hydrotribromide
[Synonym ]:
Pyrrolidin-2-on,Verbindung mit Bromwasserstoff und Brom
3-Cyanobenzoic acid
PYRROLIDINONE HYDROTRIBROMIDE
pyrrolidine hydrotribromide
pyrrolidin-2-one,compound with hydrogen bromide and bromine
MFCD00082241
2-Pyrrolidinone hydrotribromide
hydrogen tribromide
EINECS 245-100-7
PHT
PHT~Pyrrolidone hydrotribromide
Chemical & Physical Properties
[ Density]:
1.047g/cm3
[ Boiling Point ]:
245ºC at 760mmHg
[ Melting Point ]:
87-91ºC
[ Molecular Formula ]:
C4H7Br3NO
[ Molecular Weight ]:
324.81600
[ Flash Point ]:
135.5ºC
[ Exact Mass ]:
321.80800
[ PSA ]:
29.10000
[ LogP ]:
2.76200
[ Storage condition ]:
2-8C
Safety Information
[ Symbol ]:
GHS05, GHS07
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H315-H318-H335
[ Precautionary Statements ]:
P261-P280-P305 + P351 + P338
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves
[ Hazard Codes ]:
Xi:Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S26-S36
[ RIDADR ]:
NONH for all modes of transport
Preparation
Articles
Int. J. Mol. Sci. 16 , 20492-510, (2015)
Biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles, containing human parathyroid hormone (PTH (1-34)), prepared by a modified double emulsion-solvent diffusion-evaporation method, were inco...
Ornithine Transcarbamylase ArgK Plays a Dual role for the Self-defense of Phaseolotoxin Producing Pseudomonas syringae pv. phaseolicola.Sci. Rep. 5 , 12892, (2015)
Pseudomonas syringae is a phytopathogenic bacterium widely spread on terrestrial plants. Sulfodiaminophosphinyl tripeptide Phaseolotoxins (PHTs), produced by P. syringae pv. phaseolicola and P. syring...
Reversal of P-glycoprotein overexpression by Ginkgo biloba extract in the brains of pentylenetetrazole-kindled and phenytoin-treated mice.Kaohsiung J. Med. Sci. 31 , 398-404, (2015)
The purpose of this study was to investigate the combined effects of Ginkgo biloba extract and phenytoin (PHT) sodium as a dose regimen simulating the clinical treatment of patients with epilepsy, on ...